Infections with human coronaviruses (H-CoVs) result in varying clinical manifestations from mild upper respiratory symptoms to lethal pneumonia. The differing severity of diseases between the H-CoVs may be a result of dysregulated immune responses to certain H-CoVs. While the immune system can be stimulated at multiple points during H-CoV infection, viral entry is the first stimulus a host cell receives to alert the immune system of the invading pathogen. H-CoV entry begins with spike glycoproteins binding to host cellular receptors. We hypothesized that the various immune responses seen among the H-CoVs, and therefore the various diseases, can be partially explained by different spike-mediated stimulation of the immune response through differential cytokine induction. We used polarized Calu-3 cells as a model for the human respiratory tract, to which we applied purified spike protein fragments apically to trigger host cell responses. Following spike stimulation, we measured apical and basolateral secretion of interleukin-6 and -8, as these cytokines are key to initiating an immune response and have been linked to the severity of respiratory disease. Using monovalent, spike fragments appended to Fc tags, we found that SARS-CoV elicited a greater interleukin-6 and interleukin-8 response than NL63-CoV. This result is intriguing given that SARS-CoV and NL63-CoV spike glycoproteins bind the same cellular receptor, Angiotensin Converting Enzyme-2, yet NL63-CoV results in a mild disease, while SARS-CoV disease is severe. This finding suggests that the cytokine release induced by spike-receptor interactions might correlate with the H-CoV pathology. We are continuing to study the exact mechanism of cytokine release after spike binding. Using purified receptor binding domains and complete, fusion-competent spikes, we are determining the requirements for stimulation of the immune response by H-CoV entry. These studies will provide insight into the mechanism by which viral entry stimulates cytokine release, an understudied field, especially for CoVs.
